The reduced LATS2 levels detected in parathyroid adenomas are in agreement with the inhibitory effect on LATS2 expression levels exerted by miR-372, which has been found to be overexpressed in a subset of parathyroid adenomas and most parathyroid cancers [17]. This evidence concerns the gene LATS2 and parathyroid gland adenoma.